Influence of mitogen-activated protein kinase inhibitor in the process of assemble flavone of rhizome drynaria promoting the osteogentic differentiation of myoblasts

doi:10.3969/j.issn.2095-4344.2016.51.003

Abstract

Abstract:

BACKGROUND: Previous studies have confirmed that drug-containing serum with low concentration of assemble flavone of rhizome drynaria (AFDR) promotes osteogentic differentiation of ciliary neurotrophic factor (CNTF)-modified myoblasts, but the underlying mechanism remains unclear.
OBJECTIVE: To observe the influence of mitogen-activated protein kinase (MAPK) inhibitor in the process of AFDR promoting the osteogentic differentiation of myoblasts.
METHODS: Transfected-CNTF myoblasts were preprocessed prior to osteogentic induction. Changes of alkaline phosphatase specific activities were detected in blank serum, AFDR drug serum and p38 pathway inhibitor SB203580 groups. mRNA and protein expression levels of core binding factor a1 and alkaline phosphatase were detected by real-time PCR and western blot, respectively.
RESULTS AND CONCLUSION: Real-time PCR showed that the mRNA expression levels of core binding factor a1 and alkaline phosphatase in the AFDR group were the highest; while p38 inhibitor SB203580 significantly downregulated the above levels. Western blot findings showed that a significant reduction in the protein expression levels of core binding factor a1 and alkaline phosphatase after p38 inhibitor SB203580 addition. These results suggest that p38 pathway inhibitor can downregulate osteogenesis-related gene and protein expressions, and thus AFDR promoting the osteogentic differentiation of CNTF-modified myoblasts probably through activating p38 MAPK signaling pathway.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Signal Transduction, Polypodiaceae, Flavones, Tissue Engineering

CLC Number:

R318

Zhang Li, Xu Bo-xing, Li Jie, Wang Wei. Influence of mitogen-activated protein kinase inhibitor in the process of assemble flavone of rhizome drynaria promoting the osteogentic differentiation of myoblasts[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(51): 7622-7627.

Figures/Tables 3

References

[1] 李仪奎.中药药理实验方法学[M]2版.上海:上海科技技术出版社,2006:1012.

[2] 黄宏,朱方强,孙宏振,等.脂肪来源干细胞体外成骨诱导和成脂诱导分化[J].第三军医大学学报.2008,30(13): 1219-1222.

[3] 张力,王伟,范明,等.改良法体外培养大鼠成肌细胞的实验研究[J].军事医学科学院院刊,2007,31(1):62-65.

[4] 张力,王伟.负载转基因成肌细胞和骨形态发生蛋白组织工程化骨修复缺损[J].中国组织工程研究与临床康复, 2011,15(42):7791-7795.

[5] 张力,王伟.重组人骨形成蛋白2诱导成肌细胞成骨分化中的矿化反应[J].中国组织工程研究,2012,16(20): 3620- 3625.

[6] Claros S, Alonso M, Becerra J, et al. Selection and induction of rat skeletal muscle-derived cells to the chondro-osteogenic lineage. Cell Mol Biol.2008; 54(1): 1-10.

[7] Graziosi L, Menearelli A,Santorelli C,et al．Mechanistic role of p38 MAPK in gastric can cer dissemination in a rodent model peritoneal metastasis. Eur J Pharmacol. 2012;674(2/3):143-152.

[8] 张力,王伟.骨碎补总黄酮预处理转CNTF成肌细胞修复兔桡骨缺损的实验研究[J].中国老年学杂志, 2014,34 (10):2757-2759.

[9] Thouverey C,Caverzasio J.Ablation of p38αMAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency. Endocrinology. 2015;156(12):4377-4387.

[10] Leyva-Leyva M,López-Díaz A,Barrera L,et al.Differential Expression of Adhesion-Related Proteins and MAPK Pathways Lead to Suitable Osteoblast Differentiation of Human Mesenchymal Stem Cells Subpopulations. Stem Cells Dev. 2015 ;24(21):2577-2590.

[11] 曲宁宁,何丽娟,何文智,等.左、右归丸含药血清通过p38MAPK信号通路干预BMSCs成骨诱导的研究[J]. 中华中医药学刊,2016,34(6):1326-1329

[12] Yu FX,Hu WJ,He B,et al.Bone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion. World J Surg Oncol. 2015 ;13:52.

[13] 孙奇峰,尹文哲,高原,等.失重下骨碎补总黄酮经MAPK通路促间充质干细胞向成骨细胞分化研究[J].中医药学报, 2016,44(4):10-13

[14] Kocieniewski P,Faeder JR Lipniacki. The interplay of double phosphorylation and scafolding in MAPK pathways. J Theor BioL.2012;295:116-124．

[15] 闫慧明,郭静,安燕,等.分子信号通路在骨质疏松症发生机制中的研究进展[J].中国骨质疏松杂志,2016,22(10): 1336-1340.

[16] Coelho MJ, Fernandes MH. Human bone cell cultures in biocom Patibilitytesting. PartⅡ: effect of aseorbic acid, beta-glyeerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000;21(11): 1095-1102